Article Details
Retrieved on: 2021-06-09 16:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The IBRI will use Insilico's generative machine learning technology and proprietary PandaOmics Drug Discovery Platform to identify novel therapeutic ...
Article found on: www.eurekalert.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here